Tivicay® (dolutegravir) receives positive CHMP opinion in Europe for the treatment of HIV
21 November 2013 | By GlaxoSmithKline
“We welcome the CHMP’s positive opinion on dolutegravir – it puts us a step closer to offering this new treatment option to people across Europe who are living with HIV...”